Submit Deal

GENOR BIOPHARMA

Summary

Genor Biopharma is a biopharmaceutical company, which develops and commercializes therapeutic monoclonal antibodies, Fc-fusion proteins, and recombinant therapeutic proteins.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 129 M

Avg. Deal Size£ 129 M

Market Context

Senior Management

Guo Feng
CEO

Sort

01 Jun 2020|China|Biotechnology

Target: GENOR BIOPHARMA

Bidder: HILLHOUSE CAPITAL GROUP

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 129 M

Value

09 Sep 2024|China|Biotechnology

Target: GENOR BIOPHARMA

Bidder: EDDING GROUP COMPANY

3 Service Providers

2 Target | 1 Bidder

7 Dealmakers

2 Target | 5 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy